Caleium Pharm:Ph3 CAEL-101-301 AL Amyloidosis
Clinical Trial Grant
Awarded By
Caelum BioSciences, Inc
Start Date
June 16, 2021
End Date
March 28, 2025
Awarded By
Caelum BioSciences, Inc
Start Date
June 16, 2021
End Date
March 28, 2025